Total planned funding: $264,828,287
Clear active filters
Implementing Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $123,100,929 |
Uganda | $44,226,419 |
Côte d'Ivoire | $17,356,240 |
Nigeria | $15,648,856 |
Zimbabwe | $14,335,562 |
Ethiopia | $10,935,861 |
Cameroon | $7,809,175 |
Guyana | $5,314,213 |
Botswana | $3,643,348 |
Zambia | $3,427,297 |
Vietnam | $3,163,858 |
Rwanda | $3,150,000 |
Dominican Republic | $2,271,175 |
Kenya | $2,197,780 |
Namibia | $1,892,925 |
Tanzania | $1,500,000 |
Mozambique | $1,442,922 |
Haiti | $1,261,727 |
Russia | $650,000 |
Ukraine | $400,000 |
South Sudan | $330,000 |
Ghana | $300,000 |
Cambodia | $200,000 |
Angola | $150,000 |
Caribbean Region | $120,000 |
China | $0 |
Indonesia | $0 |
Thailand | $0 |
India | $0 |
Malawi | $0 |
Democratic Republic of the Congo | $0 |
Lesotho | $0 |
Eswatini | $0 |
Organizational Types
Implementing Agency | $264,828,287 |
Program Areas
Treatment | $71,509,300 |
Care | $69,735,136 |
Prevention | $67,127,557 |
Governance and Systems | $41,514,016 |
Testing | $14,842,278 |
Management and Operations | $0 |
Budget Codes
HTXS: Treatment: Adult Treatment | $55,107,146 |
HKID: Care: Orphans and Vulnerable Children | $27,275,384 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $25,858,463 |
HBHC: Care: Adult Care and Support | $21,585,127 |
HVOP: Sexual Prevention: Other Sexual Prevention | $17,984,043 |
HVTB: Care: TB/HIV | $16,758,226 |
HVSI: Strategic Information | $16,162,625 |
HVCT: Testing: HIV Testing and Counseling | $14,842,278 |
OHSS: Health Systems Strengthening | $14,833,982 |
PDTX: Treatment: Pediatric Treatment | $12,879,159 |
HLAB: Laboratory Infrastructure | $10,517,409 |
HMBL: Biomedical Prevention: Blood Safety | $9,529,391 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $7,093,688 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,279,391 |
PDCS: Care: Pediatric Care and Support | $4,116,399 |
HTXD: Treatment: ARV Drugs | $3,522,995 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $350,000 |
HMIN: Biomedical Prevention: Injection Safety | $32,581 |
HVMS: Management and Operations | $0 |
Top Partner Programs
University of the Witwatersrand:
$59,124,484
View countries
TB/HIV Care Association:
$20,253,785
View countries
Uganda Episcopal Conference:
$12,478,462
View countries